<HashMap><database>biostudies-literature</database><scores/><additional><omics_type>Unknown</omics_type><volume>6(10)</volume><submitter>Garcia-Gisbert N</submitter><pubmed_abstract>Molecular and cytogenetic studies are essential for diagnosis and prognosis in patients with myelodysplastic syndromes (MDSs). Cell-free DNA (cfDNA) analysis has been reported to be a reliable noninvasive approach for detecting molecular abnormalities in MDS; however, there is limited information about cytogenetic alterations and monitoring in cfDNA. We assessed the molecular and cytogenetic profile of a cohort of 70 patients with MDS by next-generation sequencing (NGS) of cfDNA and compared the results to sequencing of paired bone marrow (BM) DNA. Sequencing of BM DNA and cfDNA showed a comparable mutational profile (92.1% concordance), and variant allele frequencies (VAFs) strongly correlated between both sample types. Of note, SF3B1 mutations were detected with significantly higher VAFs</pubmed_abstract><journal>Blood advances</journal><pagination>3178-3188</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC9131900</full_dataset_link><repository>biostudies-literature</repository><pubmed_title>Molecular and cytogenetic characterization of myelodysplastic syndromes in cell-free DNA.</pubmed_title><pmcid>PMC9131900</pmcid><pubmed_authors>Lafuente M</pubmed_authors><pubmed_authors>Salido M</pubmed_authors><pubmed_authors>Longaron R</pubmed_authors><pubmed_authors>Espinet B</pubmed_authors><pubmed_authors>Andrade-Campos M</pubmed_authors><pubmed_authors>Merchan B</pubmed_authors><pubmed_authors>Camacho L</pubmed_authors><pubmed_authors>Garcia-Gisbert N</pubmed_authors><pubmed_authors>Arenillas L</pubmed_authors><pubmed_authors>Bellosillo B</pubmed_authors><pubmed_authors>Calvo X</pubmed_authors><pubmed_authors>Garcia-Avila S</pubmed_authors><pubmed_authors>Gibert J</pubmed_authors><pubmed_authors>Besses C</pubmed_authors><pubmed_authors>Velez P</pubmed_authors><pubmed_authors>Salar A</pubmed_authors><pubmed_authors>Fernandez-Rodriguez C</pubmed_authors><pubmed_authors>Fernandez-Ibarrondo L</pubmed_authors><pubmed_authors>Pujol RM</pubmed_authors></additional><is_claimable>false</is_claimable><name>Molecular and cytogenetic characterization of myelodysplastic syndromes in cell-free DNA.</name><description>Molecular and cytogenetic studies are essential for diagnosis and prognosis in patients with myelodysplastic syndromes (MDSs). Cell-free DNA (cfDNA) analysis has been reported to be a reliable noninvasive approach for detecting molecular abnormalities in MDS; however, there is limited information about cytogenetic alterations and monitoring in cfDNA. We assessed the molecular and cytogenetic profile of a cohort of 70 patients with MDS by next-generation sequencing (NGS) of cfDNA and compared the results to sequencing of paired bone marrow (BM) DNA. Sequencing of BM DNA and cfDNA showed a comparable mutational profile (92.1% concordance), and variant allele frequencies (VAFs) strongly correlated between both sample types. Of note, SF3B1 mutations were detected with significantly higher VAFs</description><dates><release>2022-01-01T00:00:00Z</release><publication>2022 May</publication><modification>2026-05-09T18:57:05.536Z</modification><creation>2025-04-05T19:56:26.502Z</creation></dates><accession>S-EPMC9131900</accession><cross_references><pubmed>35192693</pubmed><doi>10.1182/bloodadvances.2021006565</doi></cross_references></HashMap>